Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
casp3xenopus neuroectoderm [+] 

Too many results?Too few results?

Experiment details for casp3

Mcl1 protein levels and Caspase-7 executioner protease control axial organizer cells survival.

Mcl1 protein levels and Caspase-7 executioner protease control axial organizer cells survival.

Gene Clone Species Stages Anatomy
casp3.L laevis NF stage 13 to NF stage 14 neuroectoderm

Display additional annotations [+]
  Figure 1: Endogenous apoptosis contributes to axial organizer formation independently of Caspase3 activity (A) TUNEL-staining reveals apoptosis in the axial midline. Representative TUNEL-stained wild type (wt) stage (st.) 12 Xenopus embryos. (B) Activated Caspase-3 (Act-Casp3) is not detected before stage 14 in Xenopus embryos. Representative immuno-staining against Act-Casp3 performed on st.10 to st.14 embryos. Act-Casp3 positive nuclei are shown with black arrows; st.10 to 12 ventral view dorsal up; st. 13 and 14 dorsal view anterior up. (C-F) Endogenous apoptosis affects establishment of the posterior neural plate via its activity on axial organizer signaling independently of Casp3. (C) Xenopus embryos were injected into one dorsal blastomere at the four-cell stage with mRNA encoding (a) X. laevis bcl-xl or (b) MOcasp3 together with a tracer (red) and analyzed by ISH with sox3. Representative st.14 embryos are shown. (c) Quantification graph of (a, b). (D) Xenopus embryos were injected into one dorsal blastomere at the four- (a), sixteen- (b, c) or thirty-two- (d) cells stage with mRNA encoding X. laevis bcl-xl or MOcasp3 together with a tracer (red) and analyzed by ISH with sox3. The site of injection (red dot), and the corresponding st.14 targeted territory (red area) are represented. The graph indicates the % of embryos exhibiting the (a-c) posterior, or (d) anterior, neural plate enlargement phenotype (blue). ML: medio-lateral; L: lateral; A: anterior neural plate. (E, F) Bcl-XL acts on the axial organizer cells. Embryos were injected either in the axial organizer (notochord and floor plate) or in lateral ectoderm with (E) bcl-xl or (F) MOcasp3. Representative embryos are shown dorsal view, anterior up, except (Fc) shown dorsal-anterior view. Representative transverse sections (50μm) are shown at the antero-posterior axis positions indicated with a white-dashed arrow (Eb,d; Fb,d). The black arrow indicates the limits of the injected territory. PNE: posterior neuroepithelium. Inj: injected side. White dashed lines indicate the midline. Relative normalized expression is indicated as means ± standard error (s.e.) *** p<0.001.